Spyre Therapeutics, Inc. is a cutting-edge biotechnology company headquartered in Waltham, Massachusetts, focused on creating transformative antibody therapeutics for inflammatory bowel disease (IBD). By employing advanced antibody engineering techniques, innovative therapeutic combinations, and precision medicine strategies, Spyre aims to effectively target and address significant unmet medical needs in the management of IBD. With a strong pipeline underscored by a commitment to personalized medicine, the company is well-positioned to enhance patient outcomes and redefine treatment paradigms in this challenging therapeutic area.
Click "Analyze" to generate stock analysis
SYRE Price Trend and Signals
SYRE Option Volumes & Open Interests (aggregated)
SYRE Put Call Ratios and IV (aggregated)
SYRE Financials
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-27Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-17Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-16Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-15Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.